Unity Biotechnology
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$39,860,000 over the previous period. Total operating expenses were $44,667,000.
Profit Margin
| 2016 | 0 | -30.40M | |
|---|---|---|---|
| 2017 | 1.38M | -44.65M | -3231.26% |
| 2018 | 0 | -76.39M | |
| 2019 | 0 | -74.87M | |
| 2020 | 0 | -91.86M | |
| 2021 | 4.78M | -60.03M | -1255% |
| 2022 | 236K | -57.74M | -24469.07% |
| 2023 | 0 | -39.86M |
0YC0.L Income Statement (2016 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 0 | 236K | 4.78M | 0 | 0 | 0 | 1.38M | 0 |
Cost of revenue | 19.69M | 2.18M | 2.88M | 3.44M | 2.66M | 0 | 37.37M | 0 |
Gross profit | -19.69M | -1.94M | 1.90M | -3.44M | -2.66M | 0 | -35.99M | 0 |
Operating exp. | ||||||||
Research and development | 20.09M | 36.85M | 38.39M | 67.30M | 70.95M | 58.90M | 37.37M | 13.70M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 44.66M | 57.80M | 61.44M | 91.33M | 91.00M | 74.92M | 46.99M | 18.84M |
Operating income | -44.66M | -57.57M | -56.66M | -93.93M | -89.65M | -79.46M | -45.60M | -18.84M |
Other income (expenses), net | 4.80M | -2.35M | -4.06M | 86K | 7.47M | -4.78M | 952K | -9.37M |
Income before tax | -39.86M | -59.92M | -60.72M | -93.84M | -82.17M | -76.39M | -44.65M | -30.40M |
Income tax expense | 0 | -2.18M | -686K | -1.97M | -7.30M | 3.06M | -1.05M | 11.56M |
Net income | -39.86M | -57.74M | -60.03M | -91.86M | -74.87M | -76.39M | -44.65M | -30.40M |
Earnings per share | ||||||||
Basic EPS | -2.7 | -6.08 | -10.76 | -18.06 | -17.16 | -27.02 | -129.91 | -88.45 |
Diluted EPS | -2.7 | -6.08 | -10.76 | -18.06 | -17.16 | -27.02 | -129.91 | -88.45 |
| Data source | Data source | Data source | Data source | Data source | Data source |